These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Influence of human wet cerumen on the growth of common and pathogenic bacteria of the ear. Campos A; Betancor L; Arias A; Rodríguez C; Hernández AM; López Aguado D; Sierra A J Laryngol Otol; 2000 Dec; 114(12):925-9. PubMed ID: 11177359 [TBL] [Abstract][Full Text] [Related]
3. Bactericidal activity of wet cerumen. Stone M; Fulghum RS Ann Otol Rhinol Laryngol; 1984; 93(2 Pt 1):183-6. PubMed ID: 6370076 [TBL] [Abstract][Full Text] [Related]
4. Antibacterial and antifungal properties of human cerumen. Lum CL; Jeyanthi S; Prepageran N; Vadivelu J; Raman R J Laryngol Otol; 2009 Apr; 123(4):375-8. PubMed ID: 18694532 [TBL] [Abstract][Full Text] [Related]
5. Has cerumen a protective role in recurrent external otitis? Pata YS; Ozturk C; Akbas Y; Gorur K; Unal M; Ozcan C Am J Otolaryngol; 2003; 24(4):209-12. PubMed ID: 12884208 [TBL] [Abstract][Full Text] [Related]
6. Study of common aerobic flora of human cerumen. Campos A; Arias A; Betancor L; Rodríguez C; Hernández AM; López Aguado D; Sierra A J Laryngol Otol; 1998 Jul; 112(7):613-6. PubMed ID: 9775288 [TBL] [Abstract][Full Text] [Related]
7. Microbiology of normal external auditory canal. Stroman DW; Roland PS; Dohar J; Burt W Laryngoscope; 2001 Nov; 111(11 Pt 1):2054-9. PubMed ID: 11801996 [TBL] [Abstract][Full Text] [Related]
8. Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011-2012). Sader HS; Mendes RE; Farrell DJ; Flamm RK; Jones RN Pediatr Infect Dis J; 2014 Aug; 33(8):837-42. PubMed ID: 25222304 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin. Nishino T; Otsuki M; Hatano K; Nishihara Y Chemotherapy; 1994; 40(3):167-82. PubMed ID: 8205935 [TBL] [Abstract][Full Text] [Related]
10. Management of the ear canal seborrhea with cerumen. Storrs LA Laryngoscope; 1981 Aug; 91(8):1231-3. PubMed ID: 6455578 [TBL] [Abstract][Full Text] [Related]
11. [Dimorphism of cerumen, facts and theory]. Meyer zum Gottesberge A; Meyer zum Gottesberge A Laryngorhinootologie; 1995 Oct; 74(10):606-10. PubMed ID: 8672199 [TBL] [Abstract][Full Text] [Related]
12. Bacteriostatic and Bactericidal Activity of Deer Musk on Multidrug Resistance Bacteria. Yosef Shami A; Almasri A Pak J Biol Sci; 2018 Jan; 21(7):331-339. PubMed ID: 30417993 [TBL] [Abstract][Full Text] [Related]
13. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1995)]. Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kawaguchi H; Shimizu Y; Matsumiya H; Saito A; Terai T; Inoue H; Nakadate T; Ito C; Yosida T; Tanno Y; Ohno I; Nishioka K; Arakawa M; Igarashi K; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Touyama M Jpn J Antibiot; 1997 May; 50(5):421-59. PubMed ID: 9212366 [TBL] [Abstract][Full Text] [Related]
14. Cerumen impaction. Jabor MA; Amedee RG J La State Med Soc; 1997 Oct; 149(10):358-62. PubMed ID: 9347631 [TBL] [Abstract][Full Text] [Related]
15. In vitro activity of gemifloxacin against a broad range of recent clinical isolates from the USA. McCloskey L; Moore T; Niconovich N; Donald B; Broskey J; Jakielaszek C; Rittenhouse S; Coleman K J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():13-21. PubMed ID: 10824027 [TBL] [Abstract][Full Text] [Related]
16. External Auditory Canal Dimensions, Age, and Cerumen Retention or Impaction in Persons With Down Syndrome. Dy AES; Lapeña JFF Ann Otol Rhinol Laryngol; 2018 Apr; 127(4):253-257. PubMed ID: 29426243 [TBL] [Abstract][Full Text] [Related]
17. In vitro antibacterial activity of FK041, a new orally active cephalosporin. Watanabe Y; Hatano K; Matsumoto Y; Tawara S; Yamamoto H; Kawabata K; Takasugi H; Matsumoto F; Kuwahara S J Antibiot (Tokyo); 1999 Jul; 52(7):649-59. PubMed ID: 10513845 [TBL] [Abstract][Full Text] [Related]
18. In-vitro interaction of azithromycin and fluoroquinolones against gram-positive and gram-negative bacteria. Ruble MW; Gilbert DH; Zinner SH Clin Microbiol Infect; 1996 Mar; 1(3):183-189. PubMed ID: 11866755 [TBL] [Abstract][Full Text] [Related]
19. In vitro antibacterial activity of FK482, a new orally active cephalosporin. Mine Y; Kamimura T; Watanabe Y; Tawara S; Matsumoto Y; Shibayama F; Kikuchi H; Takaya T; Kuwahara S J Antibiot (Tokyo); 1988 Dec; 41(12):1873-87. PubMed ID: 3264828 [TBL] [Abstract][Full Text] [Related]